Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Bowen's Disease × 1 year × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 47 Prostatic Neoplasms 22 Neoplasms 19 Multiple Myeloma 16 Papillomavirus Infections 12 Carcinoma, Non-Small-Cell Lung 12 Carcinoma, Hepatocellular 12 Stomach Neoplasms 11 Colorectal Neoplasms 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Lung Neoplasms 9 Pain, Postoperative 8 Neoplasm Metastasis 8 Waldenstrom Macroglobulinemia 6 Recurrence 6 Polycystic Ovary Syndrome 6 Ovarian Neoplasms 6 Melanoma 6 Hematologic Neoplasms 6 Lymphoma, Non-Hodgkin 5 Lymphoma, Follicular 5 Leukemia, Myeloid, Acute 5 Leiomyoma 5 Kidney Neoplasms 5 Agnosia 5 Venous Thromboembolism 4 Urinary Bladder Neoplasms 4 Thyroid Neoplasms 4 Smoking Cessation 4 Pain 4

Interventions

methyl 5-aminolevulinate 1 Myelin and Lymphocyte-Associated Proteolipid Proteins 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03909646 2025-05-06

BOWTIE

Maastricht University Medical Center

Phase 4 Completed

Bowen's Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡